Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
US Department of Justice
Merck
Fish and Richardson
AstraZeneca
Accenture
Chinese Patent Office
Johnson and Johnson
Baxter

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,658,205

« Back to Dashboard

Summary for Patent: 8,658,205
Title:Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
Abstract: The present invention describes processes for the preparation of a lipid blend and a uniform filterable phospholipid suspension containing the lipid blend, such suspension being useful as an ultrasound contrast agent.
Inventor(s): Hui; Poh K. (Wellesley Hills, MA), Bishop; John E. (Groton, MA), Madrigal, Jr.; Eleodoro S. (Westford, MA)
Assignee: Lantheus Medical Imaging, Inc. (North Billerica, MA)
Application Number:13/195,734
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 8,658,205

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Lantheus Medcl DEFINITY perflutren INJECTABLE;INTRAVENOUS 021064-001 Jul 31, 2001 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,658,205

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,747,892 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend ➤ Sign Up
9,545,457 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend ➤ Sign Up
8,084,056 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend ➤ Sign Up
8,685,441 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
US Department of Justice
Mallinckrodt
McKesson
Harvard Business School
Express Scripts
UBS
Chinese Patent Office
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.